CAJ | 학술논문

冠状动脉粥样硬化性心脏病（冠心病）在全球范围内已成为威胁人类健康的重大疾病。目前，经皮冠状动脉介入（ PCI）是治疗冠心病的最有效手段之一，但术后部分患者出现了不同程度的临床不良事件。研究表明，PCI操作可激活冠状动脉及全身炎症反应，且贯穿于心脏不良事件的发生、发展过程。抑制炎症激活可以作为控制PCI术后心脏不良事件的重要途径。丹红等中药注射液可能通过多向性效应抑制PCI术后炎症激活，故中药注射液可作为PCI围术期改善预后的有效干预措施。
관상동맥죽양경화성심장병（관심병）재전구범위내이성위위협인류건강적중대질병。목전，경피관상동맥개입（ PCI）시치료관심병적최유효수단지일，단술후부분환자출현료불동정도적림상불량사건。연구표명，PCI조작가격활관상동맥급전신염증반응，차관천우심장불량사건적발생、발전과정。억제염증격활가이작위공제PCI술후심장불량사건적중요도경。단홍등중약주사액가능통과다향성효응억제PCI술후염증격활，고중약주사액가작위PCI위술기개선예후적유효간예조시。
Coronary heart disease ( CHD ) has become a primary threat to human health all over the world.Currently,percutaneous coronary intervention(PCI) is one of the most effective strategies for CHD therapy.However,the patients undergoing PCI may suffer some adverse clinical events.It is found that PCI can activate coronary artery and systemic inflammatory response which exists throughout the process of the adverse cardiac events.Hence,inflammation inhibition can be for adverse cardiac events after PCI .Danhong and other Chinese injections may inhibit inflammatory reaction in patients after PCI,therefore can be used as an effective intervention to improve prognosis of PCI.